Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share ("EPS") (Details 2)

v3.21.1
Earnings Per Share ("EPS") (Details 2) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Conversion of common units    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 1,246 1,226
Conversion of redeemable noncontrolling interests    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 940 1,011
Conversion of Series I preferred units    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 0 176
Weighted average restricted shares and deferred shares    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 419 440
Weighted average unvested TB-PIUs    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 131 75
Weighted average unvested PB-PIUs    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 228